Cite
HARVARD Citation
Bourliere, M. et al. (n.d.). A168 USE OF LEDIPASVIR/SOFOSBUVIR (LDV/SOF) WITH OR WITHOUT RIBAVIRIN (RBV) IN GENOTYPE 1 (GT 1) HCV-INFECTED PATIENTS POST LIVER TRANSPLANT (LT): EVALUATION OF SEVERAL REAL-WORLD DATASETS (RWD). Journal of the Canadian Association of Gastroenterology. pp. 291-292. [Online].